Effectiveness of the BBV-152 and AZD1222 vaccines among adult patients hospitalized in tertiary hospitals in Odisha with symptomatic respiratory diseases: A test-negative case–control study

Two vaccines, namely BBV-152 (COVAXIN(®)) and AZD1222 (COVISHIELD™), were deployed against SARS-CoV-2 in India from January 16, 2021. Frontline health care workers were vaccinated first, followed by the adult population. However, limited data on vaccine effectiveness are available for the population...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhattacharya, Debdutta, Kanungo, Srikanta, Palo, Subrata Kumar, Kshatri, Jaya Singh, Pattnaik, Matrujyoti, Ghosal, Shishirendu, Mohapatra, Pranab, Rao, C. Mohan, Sahoo, Avinav, Mishra, Rudra Prasanna, Mishra, Sanghamitra, Mohanta, Amiya Ranjan, Doley, Chinki, Pati, Sanghamitra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9852818/
https://www.ncbi.nlm.nih.gov/pubmed/36684990
http://dx.doi.org/10.3389/fpubh.2022.1041586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9852818/
https://www.ncbi.nlm.nih.gov/pubmed/36684990
http://dx.doi.org/10.3389/fpubh.2022.1041586

Ejemplares similares